請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44521完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳為堅 | |
| dc.contributor.author | Yun-Hsuan Wu | en |
| dc.contributor.author | 吳韻璇 | zh_TW |
| dc.date.accessioned | 2021-06-15T03:02:43Z | - |
| dc.date.available | 2014-09-16 | |
| dc.date.copyright | 2009-09-16 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-30 | |
| dc.identifier.citation | Arrang, J. M., Garbarg, M., Lancelot, J. C., Lecomte, J. M., Pollard, H., Robba, M., Schunack, W. & Schwartz, J. C. (1987). Highly potent and selective ligands for histamine H3-receptors. Nature 327, 117-123.
Bacciottini, L., Passani, M. B., Mannaioni, P. F. & Blandina, P. (2001). Interactions between histaminergic and cholinergic systems in learning and memory. Behav Brain Res 124, 183-194. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265. Bearden, C. E., Reus, V. I. & Freimer, N. B. (2004). Why genetic investigation of psychiatric disorders is so difficult. Curr Opin Genet Dev 14, 280-286. Beck, L. H., Bransome, E. D., Jr., Mirsky, A. F., Rosvold, H. E. & Sarason, I. (1956). A continuous performance test of brain damage. J Consult Psychol 20, 343-350. Benjamini, Y. & Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57, 289-300. Brown, D. D., Tomchick, R. & Axelrod, J. (1959). The distribution and properties of a histamine-methylating enzyme. J Biol Chem 234, 2948-2950. Cannon, T. D., Kaprio, J., Lonnqvist, J., Huttunen, M. & Koskenvuo, M. (1998). The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 55, 67-74. Cardno, A. G., Marshall, E. J., Coid, B., Macdonald, A. M., Ribchester, T. R., Davies, N. J., Venturi, P., Jones, L. A., Lewis, S. W., Sham, P. C., Gottesman, II, Farmer, A. E., McGuffin, P., Reveley, A. M. & Murray, R. M. (1999). Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 56, 162-168. Chen, W. J. & Faraone, S. V. (2000). Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet 97, 52-57. Chen, W. J., Liu, S. K., Chang, C. J., Lien, Y. J., Chang, Y. H. & Hwu, H. G. (1998). Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry 155, 1214-1220. Cheverud, J. M. (2001). A simple correction for multiple comparisons in interval mapping genome scans. Heredity 87, 52-58. Condray, R. & Steinhauer, S. R. (1992). Schizotypal personality disorder in individuals with and without schizophrenic relatives: similarities and contrasts in neurocognitive and clinical functioning. Schizophr Res 7, 33-41. Cornblatt, B. A. & Keilp, J. G. (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 20, 31-46. Crow, T. J. (2007). How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry 164, 13-21. Day, M., Pan, J. B., Buckley, M. J., Cronin, E., Hollingsworth, P. R., Hirst, W. D., Navarra, R., Sullivan, J. P., Decker, M. W. & Fox, G. B. (2007). Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test. Biochem Pharmacol 73, 1123-1134. de Almeida, M. A. & Izquierdo, I. (1986). Memory facilitation by histamine. Arch Int Pharmacodyn Ther 283, 193-198. Deutsch, S. I., Rosse, R. B., Kendrick, K. A., Fay-McCarthy, M., Collins, J. P., Jr. & Wyatt, R. J. (1993). Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data. Clin Neuropharmacol 16, 518-524. Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M., Cowart, M. D. & Brioni, J. D. (2008). The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol 154, 1166-1181. Garbarg, M., Arrang, J. M., Rouleau, A., Ligneau, X., Tuong, M. D., Schwartz, J. C. & Ganellin, C. R. (1992). S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. J Pharmacol Exp Ther 263, 304-310. Giovannini, M. G., Bartolini, L., Bacciottini, L., Greco, L. & Blandina, P. (1999). Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. Behav Brain Res 104, 147-155. Gourion, D., Goldberger, C., Leroy, S., Bourdel, M. C., Olie, J. P. & Krebs, M. O. (2005). Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport 16, 1407-1410. Harvey, P. D., Keefe, R. S. E., Mitroupolou, V., DuPre, R., Roitman, S. L., Mohs, R. C. & Siever, L. J. (1996). Information-processing markers of vulnerability to schizophrenia: performance of patients with schizotypal and nonschizotypal personality disorders. Psychiatry Res 60, 49-56. Hauser, E. R., Watanabe, R. M., Duren, W. L., Bass, M. P., Langefeld, C. D. & Boehnke, M. (2004). Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol 27, 53-63. Hedrick, P. W. (1987). Gametic disequilibrium measures: proceed with caution. Genetics 117, 331-341. Heleniak, E. & O'Desky, I. (1999). Histamine and prostaglandins in schizophrenia: revisited. Med Hypotheses 52, 37-42. Hochberg, Y. (1988). A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75, 800-802. Holm, S. (1979). A Simple Sequentially Rejective Multiple Test Procedure. Scandinavian Journal of Statistics 6, 65-70. Huston, J. P., Wagner, U. & Hasenohrl, R. U. (1997). The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res 83, 97-105. Hwu, H. G., Faraone, S. V., Liu, C. M., Chen, W. J., Liu, S. K., Shieh, M. H., Hwang, T. J., Tsuang, M. M., OuYang, W. C., Chen, C. Y., Chen, C. C., Lin, J. J., Chou, F. H., Chueh, C. M., Liu, W. M., Hall, M. H. & Tsuang, M. T. (2005). Taiwan schizophrenia linkage study: the field study. Am J Med Genet B Neuropsychiatr Genet 134B, 30-36. Itoh, Y., Oishi, R., Nishibori, M. & Saeki, K. (1991). Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis. J Neurochem 56, 769-774. Iwabuchi, K., Ito, C., Tashiro, M., Kato, M., Kano, M., Itoh, M., Iwata, R., Matsuoka, H., Sato, M. & Yanai, K. (2005). Histamine H1 receptors in schizophrenic patients measured by positron emission tomography. Eur Neuropsychopharmacol 15, 185-191. Jones, L. A., Cardno, A. G., Sanders, R. D., Owen, M. J. & Williams, J. (2001). Sustained and selective attention as measures of genetic liability to schizophrenia. Schizophr Res 48, 263-272. Kamei, C., Chung, Y. H. & Tasaka, K. (1990). Influence of certain H1-blockers on the step-through active avoidance response in rats. Psychopharmacology (Berl) 102, 312-318. Kamei, C., Okumura, Y. & Tasaka, K. (1993). Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology (Berl) 111, 376-382. Kaminsky, R., Moriarty, T. M., Bodine, J., Wolf, D. E. & Davidson, M. (1990). Effect of famotidine on deficit symptoms of schizophrenia. Lancet 335, 1351-1352. Kendler, K. S. & MacLean, C. J. (1990). Estimating familial effects on age at onset and liability to schizophrenia. I. Results of a large sample family study. Genet Epidemiol 7, 409-417. Kirkby, D. L. & Higgins, G. A. (1998). Characterization of perforant path lesions in rodent models of memory and attention. Eur J Neurosci 10, 823-838. Laird, N. M., Horvath, S. & Xu, X. (2000). Implementing a unified approach to family-based tests of association. Genet Epidemiol 19 Suppl 1, S36-42. Li, J. & Ji, L. (2005). Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95, 221-227. Lien, Y. J., Hsiao, P. C., Liu, C. M., Faraone, S. V., Tsuang, M. T., Hwu, H. G. & Chen, W. J. (2009). Genetic Linkage Evidence for Distinct Subtypes of Schizophrenia Characterized by Age at Onset and Neurocognitive Deficits. Arch Gen Psychiatry, (submitted) Ligneau, X., Landais, L., Perrin, D., Piriou, J., Uguen, M., Denis, E., Robert, P., Parmentier, R., Anaclet, C., Lin, J. S., Burban, A., Arrang, J. M. & Schwartz, J. C. (2007). Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73, 1215-1224. Ligneau, X., Lin, J., Vanni-Mercier, G., Jouvet, M., Muir, J. L., Ganellin, C. R., Stark, H., Elz, S., Schunack, W. & Schwartz, J. (1998). Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 287, 658-666. Liu, S. K., Chen, W. J., Chang, C. J. & Lin, H. N. (2000). Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol. Neuropsychopharmacology 22, 311-319. Liu, S. K., Chiu, C. H., Chang, C. J., Hwang, T. J., Hwu, H. G. & Chen, W. J. (2002). Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry 159, 975-982. Martinez-Mir, M. I., Pollard, H., Moreau, J., Traiffort, E., Ruat, M., Schwartz, J. C. & Palacios, J. M. (1993). Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models. Synapse 15, 209-220. Maxwell, M. (1992). Family interview for genetic studies. Clinical Neurogenetic Branch, Intramural Research Program, NIMH. Miyazaki, S., Imaizumi, M. & Onodera, K. (1995). Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice. Life Sci 56, 1563-1570. Nakai, T., Kitamura, N., Hashimoto, T., Kajimoto, Y., Nishino, N., Mita, T. & Tanaka, C. (1991). Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiatry 30, 349-356. Nurnberger, J. I., Jr., Blehar, M. C., Kaufmann, C. A., York-Cooler, C., Simpson, S. G., Harkavy-Friedman, J., Severe, J. B., Malaspina, D. & Reich, T. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51, 849-859; discussion 863-844. Nyholt, D. R. (2004). A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74, 765-769. Nyholt, D. R. (2005). Evaluation of Nyholt's procedure for multiple testing correction - author's reply. Hum Hered 60, 61-62. Passani, M. B., Bacciottini, L., Mannaioni, P. F. & Blandina, P. (2000). Central histaminergic system and cognition. Neurosci Biobehav Rev 24, 107-113. Porteous, D. J., Evans, K. L., Millar, J. K., Pickard, B. S., Thomson, P. A., James, R., MacGregor, S., Wray, N. R., Visscher, P. M., Muir, W. J. & Blackwood, D. H. (2003). Genetics of schizophrenia and bipolar affective disorder: strategies to identify candidate genes. Cold Spring Harb Symp Quant Biol 68, 383-394. Prast, H., Argyriou, A. & Philippu, A. (1996). Histaminergic neurons facilitate social memory in rats. Brain Res 734, 316-318. Prell, G. D., Green, J. P., Kaufmann, C. A., Khandelwal, J. K., Morrishow, A. M., Kirch, D. G., Linnoila, M. & Wyatt, R. J. (1995). Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14, 93-104. Preuss, C. V., Wood, T. C., Szumlanski, C. L., Raftogianis, R. B., Otterness, D. M., Girard, B., Scott, M. C. & Weinshilboum, R. M. (1998). Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 53, 708-717. Price, R. A., Scott, M. C. & Weinshilboum, R. M. (1993). Genetic segregation analysis of red blood cell (RBC) histamine N-methyltransferase (HNMT) activity. Genet Epidemiol 10, 123-131. Quach, T. T., Duchemin, A. M., Rose, C. & Schwartz, J. C. (1979). In vivo occupation of cerebral histamine H1-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs. Eur J Pharmacol 60, 391-392. Richelson, E. & Souder, T. (2000). Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 68, 29-39. Rizk, A., Curley, J., Robertson, J. & Raber, J. (2004). Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neurosci 19, 1992-1996. Robbins, T. W. (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163, 362-380. Rosse, R. B., Kendrick, K., Fay-McCarthy, M., Prell, G. D., Rosenberg, P., Tsui, L. C., Wyatt, R. J. & Deutsch, S. I. (1996). An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. Clin Neuropharmacol 19, 341-348. Sanders, A. R., Duan, J., Levinson, D. F., Shi, J., He, D., Hou, C., Burrell, G. J., Rice, J. P., Nertney, D. A., Olincy, A., Rozic, P., Vinogradov, S., Buccola, N. G., Mowry, B. J., Freedman, R., Amin, F., Black, D. W., Silverman, J. M., Byerley, W. F., Crowe, R. R., Cloninger, C. R., Martinez, M. & Gejman, P. V. (2008). No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 165, 497-506. Schwartz, J. C. (1975). Histamine as a transmitter in brain. Life Sci 17, 503-517. Schwartz, J. C., Arrang, J. M., Garbarg, M., Pollard, H. & Ruat, M. (1991). Histaminergic transmission in the mammalian brain. Physiol Rev 71, 1-51. Scott, M. C., Van Loon, J. A. & Weinshilboum, R. M. (1988). Pharmacogenetics of N-methylation: heritability of human erythrocyte histamine N-methyltransferase activity. Clin Pharmacol Ther 43, 256-262. Sullivan, P. F. (2008). The dice are rolling for schizophrenia genetics. Psychol Med 38, 1693-1696; discussion 1818-1620. Suvisaari, J. M., Haukka, J., Tanskanen, A. & Lonnqvist, J. K. (1998). Age at onset and outcome in schizophrenia are related to the degree of familial loading. Br J Psychiatry 173, 494-500. Suwa, H., Matsushima, E., Ohta, K. & Mori, K. (2004). Attention disorders in schizophrenia. Psychiatry Clin Neurosci 58, 249-256. Szatmari, P., Maziade, M., Zwaigenbaum, L., Merette, C., Roy, M. A., Joober, R. & Palmour, R. (2007). Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 144B, 581-588. Tsuang, H. C., Lin, S. H., Liu, S. K., Hsieh, M. H., Hwang, T. J., Liu, C. M., Hwu, H. G. & Chen, W. J. (2006). More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones. Schizophr Res 87, 172-180. Tsuang, M. T. (2001). Defining alternative phenotypes for genetic studies: what can we learn from studies of schizophrenia? Am J Med Genet 105, 8-10. Ueland, T., Oie, M., Inge Landro, N. & Rund, B. R. (2004). Cognitive functioning in adolescents with schizophrenia spectrum disorders. Psychiatry Res 126, 229-239. Westfall, P. H. & Young, S. S. (1993). Resampling-based multiple testing: Examples and methods for p-value adjustment. Wiley-Interscience. Yamauchi, K., Sekizawa, K., Suzuki, H., Nakazawa, H., Ohkawara, Y., Katayose, D., Ohtsu, H., Tamura, G., Shibahara, S., Takemura, M. & et al. (1994). Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol 267, L342-349. Yan, L., Szumlanski, C. L., Rice, S. R., Sobell, J. L., Lachman, H. M. & Weinshilboum, R. M. (2000). Histamine N-methyltransferase functional polymorphism: lack of association with schizophrenia. Am J Med Genet 96, 404-406. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44521 | - |
| dc.description.abstract | 目的：利用家關聯性分析探討組織胺甲基轉換酶基因（HNMT）和精神分裂症之早發型及持續性注意力缺損之家族之間的關係。
方法：此研究樣本使用排序子集之連鎖分析（OSA）從台灣連鎖精神分裂症研究（TSLS）選取出206個早發且持續性注意力缺損家庭。所有參與研究的個案均由受過訓練的研究助理進行遺傳診斷問卷（DIGS）的訪談與抽血。使用ABI7900進行HNMT上的6個單核苷酸多型性（SNP）的鑑定，並採用FBAT軟體來家族資料之單一基因座與半形關聯性分析。並且使用SNPSpD軟體執行有效標記數量之估計，以便進行多重檢定之校正。 結果：針對206個家庭進行單一基因座關聯性分析當中，沒有任何人的單核苷酸多型性與精神分裂症有相關性存在。另外進行兩、三、四、五、六個標記之半形關聯性分析後，我們發現在Nyholt所提出之多重檢定校正方法下，rs3100701－rs3791244－rs3791242－rs11558538半形與有早發性及持續性注意力缺損之精神分裂症家庭有相關存在。 結論：根據研究中之初步統計結果，我們推論在HNMT基因與早發性及持續性注意力缺損之精神分裂症家庭之間是有相關性存在，因此在未來當中使用獨立樣本再次進行分析是必須的。 | zh_TW |
| dc.description.abstract | Objective. To examine the association between histamine N-methyltransferase (HNMT) gene and schizophrenia with early onset and sustained attention deficit using family-based association.
Methods. The families in this study were part of the sample from the Taiwan Schizophrenia Linkage Study (TSLS) on the basis of a previous ordered subset analysis (OSA): 206 families of patients with early onset and sustained attention deficits. All participants were interviewed by trained research assistants who used the Diagnostic Interview for Genetic Studies (DIGS), and drawn for peripheral blood. Six SNPs of the HNMT gene were genotyped and FBAT program was used to perform single-locus and haplotype association analyses. Multiple testing was adjusted by means of effective marker number estimated using SNPSpD program. Results. There was no association between individual SNPs of HNMT and schizophrenia in this subset of families. When employing two-, three-, four-, five-, and six-marker sliding window analysis for haplotype association in these families, the result for the four-marker haplotype of rs3100701-rs3791244-rs3791242-rs11558538 haplotype A-G-T-G with schizophrenia had a p-value of 0.012, which was smaller than the threshold for significance (0.013) when adjusted for the effective marker number of four in this study. Conclusions. There was a significant association between HNMT gene and schizophrenia with early onset and sustained attention deficits, and future replication in independent samples is warranted | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T03:02:43Z (GMT). No. of bitstreams: 1 ntu-98-R96842016-1.pdf: 225065 bytes, checksum: bffe6521479dd1bb40666780eb7c507f (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 致謝 I
摘要 II ABSTRACT III CONTENT IV LIST OF TABLES V LIST OF FIGURES VI INTRODUCTION 1 Candidate subphenotypes of schizophrenia 1 Novel finding in ordered subset analysis 2 Histamine N-methyltransferase gene and schizophrenia 2 MATERIALS AND METHODS 5 Subjects 5 Measurement 5 SNP Genotyping 6 Statistical analysis 6 RESULTS 8 Sample characteristics 8 Allele frequency 8 Construction of Haplotypes 8 Family-based association analysis 8 DISCUSSION 10 REFERENCES 14 SUPPLEMENTARY MATERIALS 29 | |
| dc.language.iso | en | |
| dc.subject | 持續性注意力缺損 | zh_TW |
| dc.subject | 家族關聯性 | zh_TW |
| dc.subject | 組織胺甲基轉換酶 | zh_TW |
| dc.subject | 基因 | zh_TW |
| dc.subject | 精神分裂症 | zh_TW |
| dc.subject | 早發型 | zh_TW |
| dc.subject | family-based association | en |
| dc.subject | schizophrenia | en |
| dc.subject | histamine N-methyltransferase | en |
| dc.title | 組織胺甲基轉換酶基因與精神分裂症之早發型及持續性注意力缺損之家族關聯研究 | zh_TW |
| dc.title | A Family-based Association Study of Histamine N-methyltransferase Gene and Schizophrenia with Early Onset and Sustained Attention Deficits | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 胡海國,蕭朱杏,賴文崧 | |
| dc.subject.keyword | 家族關聯性,組織胺甲基轉換酶,基因,精神分裂症,早發型,持續性注意力缺損, | zh_TW |
| dc.subject.keyword | family-based association,histamine N-methyltransferase,schizophrenia, | en |
| dc.relation.page | 34 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-07-30 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學研究所 | zh_TW |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 219.79 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。